Literature DB >> 14505291

Tomographic coronary angiography by EBCT and MDCT.

Stephan Achenbach1, Udo Hoffmann, Maros Ferencik, Stephan Wicky, Thomas J Brady.   

Abstract

Fast, cross-sectional computed tomography (CT) imaging permits visualization of the coronary artery lumen after intravenous injection of contrast agent. Electron beam CT and multidetector row spiral CT have both been shown to allow detection of coronary artery stenoses with high sensitivity and specificity in selected patient subsets. However, limitations of image quality may render some coronary artery segments unevaluable, in most cases because of severe calcification or remaining motion artifacts. In the future, these imaging modalities may play a clinically important role in ruling out coronary artery stenoses, especially in patients with relatively low likelihood of disease. Other applications include the analysis of bypass patency and evaluation of coronary anomalies.

Entities:  

Mesh:

Year:  2003        PMID: 14505291     DOI: 10.1016/s0033-0620(03)00086-0

Source DB:  PubMed          Journal:  Prog Cardiovasc Dis        ISSN: 0033-0620            Impact factor:   8.194


  4 in total

1.  Coronary calcium score from multislice computed tomography correlates with QT dispersion and left ventricular wall thickness.

Authors:  Nan-Hung Pan; Hung-Yu Yang; Ming-Hsiung Hsieh; Yi-Jen Chen
Journal:  Heart Vessels       Date:  2008-05-17       Impact factor: 2.037

Review 2.  Nonacute coronary syndrome anginal chest pain.

Authors:  Megha Agarwal; Puja K Mehta; C Noel Bairey Merz
Journal:  Med Clin North Am       Date:  2010-03       Impact factor: 5.456

Review 3.  Role of multimodality imaging in ischemic and non-ischemic cardiomyopathy.

Authors:  Karthikeyan Ananthasubramaniam; Ritesh Dhar; João L Cavalcante
Journal:  Heart Fail Rev       Date:  2011-07       Impact factor: 4.214

4.  [Cardio-pulmonary vascular system. Three-dimensional quantitative evaluation by microcomputed tomography].

Authors:  A C Langheinrich; B Leithauser; W S Rau; R M Bohle
Journal:  Pathologe       Date:  2004-03       Impact factor: 1.011

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.